Guangdong Provincial People's Hospital: Kidney Diseases trials

The registry lists 18 Kidney Diseases studies with Guangdong Provincial People's Hospital as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 4 6No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Guideline-diRected MAnagement for Chronic Kidney Disease: EValuation of an Education Progamme in a National Cluster Randomized Controlled TrialNot yet recruitingNCT06825676Not applicable
• Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention IICompletedNCT05050877
• The Association Between sUCR and the Survival in Patients With DKDStatus unknownNCT04612595
• Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary InterventionCompletedNCT04407936
• High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal DiseaseStatus unknownNCT03456232Not applicable
• Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyStatus unknownNCT03218852Phase 4
• A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROteinCompletedNCT03170336Phase 4
• Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous NephropathyStatus unknownNCT03170323Phase 4
• Acute Myocardial Infarction and Acute Cerebral Infarction (AMIAC) Registry and Follow-upStatus unknownNCT03166696
• The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.Status unknownNCT02710747Phase 4
• Simplified Rapid Hydration in Preventing CA-AKI Among Patients With Chronic Kidney DiseaseCompletedNCT02232997Not applicable
• Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyStatus unknownNCT01758120Phase 4
• An Observational Study of IgA Nephropathy: Pathological Variants and Clinical DataCompletedNCT01502579
• REduction of rIsk for Contrast Induced NephropathyStatus unknownNCT01402232
• PREdictive Value of COntrast voluMe to creatinINe Clearance RatioCompletedNCT01400295
• Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary InterventionStatus unknownNCT01399203
• Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes NephropathyStatus unknownNCT00655330Not applicable
• A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA NephropathyCompletedNCT00426348Phase 4